SCHEMBL30848073

SCHEMBL30848073

CCc1ncc2cnn(C)c2c1NS(=O)(=O)c1cnn(-c2ccnc(C(F)(F)F)c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 2/20 0.38
▸ GRIN1 Q05586 2/20 0.38
▸ GRIN2B Q13224 2/20 0.38
▸ AR P10275 1/20 0.32
▸ OXTR P30559 1/20 0.32
▸ AVPR1A P37288 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ PSEN1 P49768 1/20 0.32
▸ PSEN2 P49810 1/20 0.32
▸ APH1B Q8WW43 1/20 0.32
▸ NCSTN Q92542 1/20 0.32
▸ APH1A Q96BI3 1/20 0.32
▸ PSENEN Q9NZ42 1/20 0.32
▸ CHRM4 P08173 1/20 0.32
▸ PTGS2 P35354 2/20 0.31
▸ PTGS1 P23219 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27133692 1.00 RXRA (0.38) RXRAGRIN1GRIN2BAROXTR
SCHEMBL30848041 0.90 RXRA (0.38) RXRAGRIN1GRIN2BAROXTR
SCHEMBL27132346 0.90 RXRA (0.38) RXRAGRIN1GRIN2BAROXTR
SCHEMBL27132958 0.86 PIK3CA (0.36) RXRAGRIN1GRIN2BAROXTR
SCHEMBL30847991 0.86 PIK3CA (0.36) RXRAGRIN1GRIN2BAROXTR
SCHEMBL30848042 0.86 RXRA (0.36) RXRAGRIN1GRIN2BAROXTR
SCHEMBL27132783 0.86 RXRA (0.36) RXRAGRIN1GRIN2BAROXTR
SCHEMBL30847769 0.86 RXRA (0.35) RXRAGRIN1GRIN2BAROXTR
SCHEMBL30847861 0.86 RXRA (0.37) RXRAGRIN1GRIN2BOXTRAVPR1A
SCHEMBL27132597 0.86 RXRA (0.35) RXRAGRIN1GRIN2BAROXTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577536-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. (US) 2025-07-02 — — EP disclosed
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback